Partner, National Sector Leader, Healthcare , KPMG (US)
By 2030, a consumer-centric healthcare system will be an imperative. Here’s how to get there.
Instead of viewing calls for transparency as a burden, pharmaceutical companies can take steps to turn pricing reform to their advantage.
2019 Health Care & Life Sciences Investment Outlook
Rising to the data challenge
Board and audit committee agendas should continue to evolve in 2019 amid the game-changing implications of technology, consolidation, and new entrants.
Reinvent innovation and become an R&D front-runner by 2030
Balancing opportunity and risk to bring your drug to this important market.
Top 5 factors every biotech and pharmaceutical company should keep in mind
Unlocking value for life sciences organizations
This CIO Survey is the largest IT leadership study in the world, and summarizes what we learned about the transformational CIO.
KPMG/RAPS survey illustrates the ground medical device companies still have to cover
Results indicate that the CIO role is transforming as organizations strive to be customer-centric in an environment of increased risk and aim to make a success of digital.
Driving value in healthcare
Finance disrupted - As the industry adjusts to continuous disruption, the finance function has an opportunity to lead
Identifying opportunities for life sciences manufacturers.
2018 Program benchmark report
News and events
View recent webcasts
Register to receive timely insights
Meet our team